FR2293219A1 - Procede d'inactivation du virus de l'herpes banal par des agents tensio-actifs et non ioniques - Google Patents

Procede d'inactivation du virus de l'herpes banal par des agents tensio-actifs et non ioniques

Info

Publication number
FR2293219A1
FR2293219A1 FR7536180A FR7536180A FR2293219A1 FR 2293219 A1 FR2293219 A1 FR 2293219A1 FR 7536180 A FR7536180 A FR 7536180A FR 7536180 A FR7536180 A FR 7536180A FR 2293219 A1 FR2293219 A1 FR 2293219A1
Authority
FR
France
Prior art keywords
banal
herpes
inactivation
virus
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7536180A
Other languages
English (en)
Other versions
FR2293219B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of FR2293219A1 publication Critical patent/FR2293219A1/fr
Application granted granted Critical
Publication of FR2293219B1 publication Critical patent/FR2293219B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7536180A 1974-12-03 1975-11-26 Procede d'inactivation du virus de l'herpes banal par des agents tensio-actifs et non ioniques Granted FR2293219A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/529,180 US4020183A (en) 1974-12-03 1974-12-03 Nonionic surface active anti-herpes simplex viral agents

Publications (2)

Publication Number Publication Date
FR2293219A1 true FR2293219A1 (fr) 1976-07-02
FR2293219B1 FR2293219B1 (fr) 1979-09-21

Family

ID=24108844

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7536180A Granted FR2293219A1 (fr) 1974-12-03 1975-11-26 Procede d'inactivation du virus de l'herpes banal par des agents tensio-actifs et non ioniques

Country Status (8)

Country Link
US (3) US4020183A (fr)
AU (1) AU504576B2 (fr)
BE (1) BE836192A (fr)
CA (1) CA1067826A (fr)
DE (1) DE2554428A1 (fr)
FR (1) FR2293219A1 (fr)
NL (1) NL7513985A (fr)
ZA (1) ZA757591B (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2507891A1 (fr) * 1981-06-18 1982-12-24 Gresval Laboratoires Medicament, notamment pour le traitement des maladies a virus du type herpes
FR2528701A1 (fr) * 1982-06-16 1983-12-23 Sanofi Sa Compositions antiseborrheiques a usage cosmetique comportant au moins un alkylphenol polyoxyethylene
EP0305551A2 (fr) * 1981-10-13 1989-03-08 Exovir, Inc. Compositions pharmaceutiques pour l'application topique
EP0466397A2 (fr) * 1990-07-10 1992-01-15 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Traitement des maladies inflammatoires avec les esters d'acides gras à longue chaîne du polyoxyéthylène sorbitane
WO1993000114A1 (fr) * 1991-06-20 1993-01-07 Viro-Tex Corporation Composition a usage local ameliorant la cicatrisation de lesions dues a l'herpes

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372977A (en) * 1977-05-31 1983-02-08 Block Drug Company, Inc. Polyoxethylene derivatives as antipruritic ectoparasiticide
US4199575A (en) * 1978-03-27 1980-04-22 Gunther Roland E Method of treating dermatitis venenata
US4657933A (en) * 1978-09-11 1987-04-14 Collins Harvey T Topical preparation and method for treating Herpes simplex virus infection
DE3001302A1 (de) * 1980-01-16 1981-07-23 Basf Ag, 6700 Ludwigshafen Verwendung von di-tert.-alkylphenolethoxylaten als loesungsvermittler fuer kosmetische und pharmazeutische praeparate
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4412985A (en) * 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
US4507281A (en) * 1981-10-13 1985-03-26 Exovir, Inc. Interferon-containing compositions
CA1190148A (fr) * 1981-10-13 1985-07-09 Samuel S. Asculai Composes contenant de l'interferon
US4581231A (en) * 1982-06-10 1986-04-08 The United States Of America As Represented By The Secretary Of Health And Human Services Inactivation of viruses containing essential lipids
US4957734A (en) * 1982-06-14 1990-09-18 Exovir, Inc. Treatment of certain skin malignancies and pre-malignant skin lesions, herpes zoster and psoriasis
US4657934A (en) * 1982-08-23 1987-04-14 Collins Harvey T Method for treating Herpes simplex virus infection and topical preparation used therein
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
US4719235A (en) * 1984-10-16 1988-01-12 Gerald N. Kern Methods and compositions for treating viral infection
IT1213453B (it) * 1985-08-02 1989-12-20 Merz & Co Gmbh & Co Composizione farmaceutica.
DE3625948A1 (de) * 1985-08-02 1987-02-19 Merz & Co Gmbh & Co Antivirale und antitumor-zusammensetzung, verfahren zu deren herstellung und deren verwendung
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
US5712257A (en) * 1987-08-12 1998-01-27 Hem Research, Inc. Topically active compositions of mismatched dsRNAs
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
AU5381590A (en) * 1989-04-24 1990-10-25 Syntex (U.S.A.) Inc. Topical antiviral pharmaceutical composition containing a nonionic surfactant
US5965524A (en) * 1989-07-07 1999-10-12 Peptide Technologies Corporation Analogs of viscosin and uses thereof
DE69034147D1 (de) * 1989-08-09 2004-07-22 Osteotech Inc Verfahren zur Desinfektion von Knochengeweben
US5513662A (en) * 1991-12-31 1996-05-07 Osteotech, Inc. Preparation of bone for transplantation
DE4344697A1 (de) * 1993-12-27 1995-06-29 Beiersdorf Ag Corticosteroide enthaltende W/O-Lotion
US5977034A (en) * 1994-08-19 1999-11-02 Lifenet Research Foundation Composition for cleaning bones
US5976104A (en) * 1994-08-19 1999-11-02 Lifenet Research Foundation Recirculation method for cleaning essentially intact bone grafts using pressure mediated flow of solutions and bone grafts produced thereby
US5797871A (en) * 1994-08-19 1998-08-25 Lifenet Research Foundation Ultrasonic cleaning of allograft bone
US5556379A (en) * 1994-08-19 1996-09-17 Lifenet Research Foundation Process for cleaning large bone grafts and bone grafts produced thereby
DE4435288A1 (de) * 1994-10-01 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen gegen Superinfektionen mit einem Gehalt an ethoxylierten und/oder propoxylierten Alkoholen und/oder Carbonsäuren
US6034073A (en) * 1995-04-24 2000-03-07 Novavax, Inc. Solvent detergent emulsions having antiviral activity
US5700842A (en) * 1995-11-01 1997-12-23 Kimberly-Clark Worldwide, Inc. Methods of incorporating a hydrophobic substance into an aqueous solution
KR100461931B1 (ko) * 1995-11-01 2005-02-28 킴벌리-클라크 월드와이드, 인크. 항미생물성조성물및그를함유하는습윤성와이프
US6015832A (en) * 1997-12-31 2000-01-18 The Regents Of The University Of Michigan Methods of inactivating bacteria including bacterial spores
US7229447B1 (en) 1998-08-25 2007-06-12 Advanced Photodynamics Technologies, Inc. Photodynamic therapy utilizing a solution of photosensitizing compound and surfactant
US8267982B2 (en) 1998-08-25 2012-09-18 Advanced Photodynamic Technologies, Inc. Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
US6455586B1 (en) * 1998-12-15 2002-09-24 Leonard L. Kaplan Topical immunomodulating compositions for treatment of aids, Hepatitis B & C, other infectious diseases, and cancer
US7655252B2 (en) * 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US8236335B2 (en) * 1999-04-28 2012-08-07 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
US6699465B2 (en) 2001-05-18 2004-03-02 Albany Medical College Covalent attachment of polymer to cell to prevent virus bonding to receptor
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US20090232748A1 (en) * 2003-11-07 2009-09-17 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US20050100601A1 (en) * 2003-11-07 2005-05-12 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
CA2604392A1 (fr) * 2005-04-11 2006-10-19 Nanobio Corporation Halogenures d'ammonium quaternaires pour le traitement de pathologies infectieuses
WO2008051186A2 (fr) * 2005-08-09 2008-05-02 Nanobio Corporation Compositions de nano-émulsion ayant une activité anti-inflammatoire
WO2008103416A1 (fr) * 2007-02-21 2008-08-28 Capps Charles L Amélioration synergique de propionate de calcium
US8747872B2 (en) 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US20090029179A1 (en) * 2007-05-14 2009-01-29 Fujifilm Corporation Two-liquid composition, hydrophilic composition and hydrophilic member
WO2010057197A1 (fr) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Compositions de vaccins contre le cancer et leurs méthodes d’utilisation
WO2010119966A1 (fr) * 2009-04-17 2010-10-21 シャボン玉石けん株式会社 Agent antiviral et produit nettoyant
EP2542058B1 (fr) 2010-03-02 2018-10-10 RXi Pharmaceuticals Corporation Dose à effet sensibilisant d'une composition topique immunomodulatrice gélifiée
EP3834851A1 (fr) 2010-12-30 2021-06-16 Laboratoire Français du Fractionnement et des Biotechnologies Glycols en tant qu'agents pathogènes inactifs
FI128711B (en) 2017-03-17 2020-10-30 Jyri Nieminen Procedure for the treatment of herpes simplex symptoms on the skin and mucous membranes of mammals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2752284A (en) * 1952-09-27 1956-06-26 Ortho Pharma Corp Spermicidal composition
US2889250A (en) * 1955-12-29 1959-06-02 Ortho Pharma Corp Spermicidal alkylphenoxy-polyethoxyethanol emulsion
NL282265A (fr) * 1961-08-22

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2507891A1 (fr) * 1981-06-18 1982-12-24 Gresval Laboratoires Medicament, notamment pour le traitement des maladies a virus du type herpes
EP0305551A2 (fr) * 1981-10-13 1989-03-08 Exovir, Inc. Compositions pharmaceutiques pour l'application topique
EP0305551A3 (fr) * 1981-10-13 1990-01-10 Exovir, Inc. Compositions pharmaceutiques pour l'application topique
FR2528701A1 (fr) * 1982-06-16 1983-12-23 Sanofi Sa Compositions antiseborrheiques a usage cosmetique comportant au moins un alkylphenol polyoxyethylene
EP0097567A2 (fr) * 1982-06-16 1984-01-04 Sanofi S.A. Utilisation d' alkylphénol polyoxyéthyléné comme agents antiséborrhéiques
EP0097567A3 (en) * 1982-06-16 1984-08-29 Sanofi, Societe Anonyme Antiseborrhoeic compositions for cosmetic use, comprising at least one polyethoxylated alkyl phenol
EP0466397A2 (fr) * 1990-07-10 1992-01-15 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Traitement des maladies inflammatoires avec les esters d'acides gras à longue chaîne du polyoxyéthylène sorbitane
EP0466397A3 (en) * 1990-07-10 1992-05-06 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of inflammatory diseases with polyoxyethylenesorbitan mono-higher-fatty acid esters
WO1993000114A1 (fr) * 1991-06-20 1993-01-07 Viro-Tex Corporation Composition a usage local ameliorant la cicatrisation de lesions dues a l'herpes

Also Published As

Publication number Publication date
AU504576B2 (en) 1979-10-18
NL7513985A (nl) 1976-06-08
ZA757591B (en) 1977-07-27
FR2293219B1 (fr) 1979-09-21
US4139630A (en) 1979-02-13
CA1067826A (fr) 1979-12-11
DE2554428C2 (fr) 1988-02-25
US4020183A (en) 1977-04-26
DE2554428A1 (de) 1976-06-10
US4147803A (en) 1979-04-03
BE836192A (fr) 1976-06-02
AU8728075A (en) 1977-06-09

Similar Documents

Publication Publication Date Title
FR2293219A1 (fr) Procede d'inactivation du virus de l'herpes banal par des agents tensio-actifs et non ioniques
FR2353484A1 (fr) Procede de preparation d'agents adsorbants carbones
FR2294999A1 (fr) Procede de preparation d'amides par hydrolyse biologique
RO72543A (fr) Procede pour la preparation des n-(3-trifluormethyle-4-halogene-phenyle)-n'-benzoilcarbamide
BE828555A (fr) Composition pour le traitement d'infections virales
FR2329678A1 (fr) Procede pour l'amelioration de l'adhesivite des caoutchoucs
FR2278267A1 (fr) Procede de multiplication acceleree de plants de fraisiers par " micropropagation in vitro " et plantules obtenues
FR2301244A1 (fr) Nouvelle preparation pharmaceutique contenant du glutamate ou de l'aspartate de magnesium
BE839836A (fr) Procede de preparation du tricosene-(9) et de l'heneicosene-(9)
BE809309A (fr) Procede pour eliminer l'amoniac
FR2349618A1 (fr) Procede de reduction de l'egouttement dans des compositions de polystyrene en flammes, par incorporation de caoutchouc de polychloroprene
FR2332965A1 (fr) Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage
FR2285377A1 (fr) Agents tensio-actifs amphoteres et procede pour leur preparation
BE840354A (fr) Procede de preparation d'agents therapeutiques
FR2300493A1 (fr) Herse souple, particulierement pour l'entretien des prairies
BE750215A (fr) Procede d'epinglage electrostatique ameliore par l'emploi d'un gaz
BE837860A (fr) Derives d'acide glycyrrhetinique et procede pour leur preparation
FR2318616A1 (fr) Groupe pour le traitement d'animaux par vaporisation
FR2304388A1 (fr) Procede d'elimination d'acide fluorhydrique de courants gazeux en contenant
FR2322544A1 (fr) Degagement de l'ethylene dans les plantes, par un melange ameliore contenant de l'acide 2-chloro-ethylphosphonique
FR2320292A1 (fr) Procede de preparation de l'equinenone
FR2276260A2 (fr) Procede d'epuration des fume
PT65165B (fr) Noveau procede de preparation du n-(l-ethyl-2-pyrrolidylmethyl)-2-methoxy-5-sulfamoyl-benzamide
FR2306209A1 (fr) Procede de preparation d'halogenures d'alcoyl-etain
FR2306200A2 (fr) Procede de preparation d'halogenures d'acides sulfamiques

Legal Events

Date Code Title Description
ST Notification of lapse